Locate Therapeutics receives Biomedical Catalyst Primer Award to develop personalised cell therapies for compromised patient populations
Locate Therapeutics, a UK regenerative medicine company, recently announced that it has received a Biomedical Catalyst Primer Award for a...
Read More